Jump Financial’s Olema Pharmaceuticals OLMA Stock Holding History

Jump Financial’s Portfolio OLMA Stock Details OLMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.27M	Sell	181,672 -271,294	-60%	-$3.63M	0.02%	844
2026 Q1	$6.75M	Buy	452,966 +352,692	+352%	+$7.85M	0.09%	260
2025 Q4	$2.51M	Buy	+100,274	New	+$1.78M	0.03%	595
2024 Q4	–	Sell	-63,041	Closed	-$753K	–	1900
2024 Q3	$753K	Buy	63,041 +32,449	+106%	+$415K	0.02%	928
2024 Q2	$331K	Buy	+30,592	New	+$332K	0.01%	1336
2024 Q1	–	Sell	-19,866	Closed	-$279K	–	2181
2023 Q4	$279K	Buy	+19,866	New	+$267K	0.01%	1383
2022 Q3	–	Sell	-30,533	Closed	-$124K	–	1843
2022 Q2	$124K	Sell	30,533 -7,967	-21%	-$25.3K	0.01%	1410
2022 Q1	$164K	Buy	38,500 +24,338	+172%	+$134K	0.01%	1348
2021 Q4	$133K	Buy	+14,162	New	+$293K	0.01%	1186

Other funds holding OLMA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Jupiter Topco New York $245B AUM

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Jump Financial's OLMA Position: Q2 2026 in Review

Jump Financial reduced its Olema Pharmaceuticals (OLMA) stake by 60% in Q2 2026, selling an estimated $3.63M and leaving 181,672 shares worth $2.27M. The position accounts for 0.02% of the portfolio, ranked #844.

Jump Financial first reported a position in OLMA in Q4 2021 and has held it in 9 quarters since. The position peaked at $6.75M in Q1 2026. 185 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

Jump Financial held 181,672 shares of Olema Pharmaceuticals worth $2.27M as of Q2 2026.
Jump Financial sold 271,294 Olema Pharmaceuticals shares in Q2 2026, an estimated $3.63M.
Olema Pharmaceuticals made up 0.02% of Jump Financial's portfolio in Q2 2026, its #844 holding.
Jump Financial first reported a position in Olema Pharmaceuticals in Q4 2021 and has held it in 9 quarters since.
Jump Financial's Olema Pharmaceuticals position peaked at $6.75M in Q1 2026.
185 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.